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Introduction
A systemic inflammatory response has been reporeted in
Acute Myocardial Infarction (AMI) with C-reactive pro-
tein (CRP) the most widely studied marker. Contrast
enhanced Magnetic Resonance Imaging (ceMRI) allows
accurate quantification of AMI size by delayed hyperen-
hancement (DE). CeMR also provides qualitative infor-
mation on AMI characteristics, known to influence
prognosis, such as microvascular obstruction (MVO).
Purpose
To investigate the relationship of inflammation to AMI
characteristics.
Methods
80 consecutive patients with first AMI underwent ceMRI at
a mean (SD) of 64 (23) hours from chest pain on a Sie-
mens Sonata 1.5 T system using a phased array chest coil
during breath-holds. Left ventricular ejection fraction
(LVEF) was evaluated using a steady state free precession
sequence. CeMRI was performed > 15 minutes after
peripheral injection of 0.2 mmol/kg gadolinium-DTPA
using a segmented gradient-echo inversion-recovery
sequence for DE and MVO. Scans were assessed by 2 expe-
rienced observers and DE was planimetered manually. 23
patients were excluded based on ceMRI findings: DE in >
1 coronary territory (n = 11); subendocardial sparing pat-
tern of DE (n = 3); and absent DE (n = 9). 57 patients (43
male) of mean (SD) age 59.8 (12.5) years were included
in final analysis. CRP concentration was measured at time
of ceMRI using an ultrasensitive double antibody sand-
wich ELISA.
Results
Patients with CRP > 10 mg/dl (75%) had a larger mean
infarct size (40.1 vs. 14.2 g, p = 0.001) and increased pro-
portion of MVO (46.5 vs 14.3%, p = 0.03). The difference
in LVEF approached significance (54.4 vs. 60.5%, p =
0.07). CRP correlates with DE (r = 0.57, p < 0.001) and
LVEF (r = -0.28, < 0.001). The area under the curve (95%
confidence interval) by ROC analysis was 0.8 (0.73–0.87)
for presence of DE and 0.75 (0.62–0.87) for MVO. Using
a cut off CRP value > 26 mg/dl the sensitivity for presence
of MVO is 0.83 and specificity 0.63, likelihood ratio 2.2.
Conclusion
CRP measured within first few days of AMI has a moderate
correlation with infarct size and LVEF by ceMRI. Moreo-
ver, a patient admitted with AMI with a CRP value of > 26
mg/dl is more than twice as likely to have microvascular
obstruction.
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